MPs and MEPs Call for TRIPS Waiver

Challenging the IP Protection Framework

Over 100 MEPs call for a TRIPS Waiver

Access to Medicines in Europe

Health Action International at 40 – A Word from Executive Director, Tim Reed


There is no UHC without Universal Medicines Coverage

HAI’s Great Health Hack Delivers Great Ideas for Access to Meds

Pharmaceutical promotion: how does it impact rational use of medicine?

Europe Faces a Critical Time of Key Medicine Shortages Amidst a Pandemic

What do the next five years have in store for the European Medicines Agency?

Dutch institutions failing to register results of clinical trials

The significant impact of Health Technology Assessment discussions on national health systems

COVID-19 risks turning back the clock on years of essential development work

Barriers and facilitators of access to Internationally Controlled Essential Medicines in Kenya

HAI Releases Annual Report 2019

Clinical trials and COVID-19

Reflections on the World Health Assembly

COVID-19 And Its Far-Reaching Health Impacts in Sub-Saharan Africa

EU Must Not Miss its Chance on WHO Technology Pool

TRIPS-flexibilities in Health Crises and Beyond


Health Technology Assessments: will 2020 end the deadlock?

Is clinical trial transparency under threat?

A Momentous Week for Access to Medicines

Lack of access to ICEMs has disastrous consequences for many. So what’s being done?

Access to ICEMs is a fundamental human right, but millions aren’t receiving them

Civil Society Voice at International Summit to Tackle Global Health Challenge of Antimicrobial Resistance

Dr Marg Ewen Receives the Helen Clark-JoPPP Award


Staff Spotlight: Jaume Vidal

Time for a Treaty? ReAct Reports on Second Consultation on Global Development & Stewardship Framework to Combat AMR

Medicijnen: de link met de maatschappij